Partners

Strategic partnerships will allow us to reach our goals

Grants

ERC PoC

PoC Validation

DTS

Biomarker Validation

CRAASH Barcelona

Program that helps European research teams launch successful diagnostic innovations to improve health and patient care

FIPSE

Ayudas para financiar estudios de viabilidad de las innovaciones en Salud

AECC INNOVA

Lead Optimization

DTS

PoC in CRC

Torres Quevedo

Ayuda PTQ2021-012018 financiada por MCIN/AEI

AGAUR Doctorat Industrial

NEOTEC

SNEO-20231204

MISIONES PERTE

MIG-20231023 – IMPACT Photonics – Investigación para la Integración de Nuevas Arquitecturas Sensoras de Fotónica Integrada Multiplexada y Terahercios Hiperespectrales para un Sistema Microfluídico In Vitro para Monitorizar Tratamientos Farmacológicos contra el Cáncer

Our investors

AtG Therapeutics is a preclinical stage drug development biotech that specialises in the discovery of metabolic adaptation targets and therapies to treat advanced cancer

AtG is currently looking for investors in order to fund the preclinical development of AtG-153.

Would it be you?